Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dubai, UAE, March 30, 2026 (GLOBE NEWSWIRE) -- Pepeto just announced that its exchange passed final testing, and the crypto news response was instant. Every major crypto outlet is covering the...
-
Hume Health Hume Band claims evaluated — Metabolic Momentum, biological age tracking, AI longevity metrics, pricing, and what to verify in 2026.
-
Los Angeles, CA, March 30, 2026 (GLOBE NEWSWIRE) -- Los Angeles, CA - March 30, 2026 - - Dropship China Pro, a global e-commerce fulfillment company serving online sellers since 2016, has...
-
SYDNEY, March 30, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Kelly Henney as a Senior Managing Director and Australia Leader of the Information...
-
Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued...
-
Carpinteria, CA, March 30, 2026 (GLOBE NEWSWIRE) -- This announcement is based on publicly available materials from ProHealth Longevity regarding its BPC-157 formulation, including how the product...
-
REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
-
Revenues of €4.5 million for the full year of 2025Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits1 as at December 31, 2025Completed a U.S. registered public...
-
PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat populationPhase 1b data demonstrate endoscopic improvement,...
-
BOCA RATON, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announces its...